New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] - Zhongcheng Tui (300208) has 11 trading days remaining until the last trading day[1] Delisting and Trading Reminders - Tui Shi Jin Gang (600190) has 11 trading days remaining until the last trading day[1] - Hengli Tui (000622) is in the delisting arrangement period with 8 trading days remaining[1] - Tui Shi Jiu You (600462) has 7 trading days remaining until the last trading day[1] Market Volatility - Beifang Changlong (301357) reported severe abnormal fluctuations[1] - Multiple companies, including Jichuan Pharmaceutical and *ST Yazhen, are under scrutiny for trading anomalies[1]

证券代码：300472 证券简称：*ST 新元 公告编号：临-2025- 079 万向新元科技股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别风险提示： 1、公司因涉嫌信息披露违法违规被证监会立案调查，最终调查结果未出， 重整推进存在重大不确定性。 公司于 2025 年 3 月 27 日收到中国证券监督管理委员会（以下简称"证监 会")下发的《立案告知书》，因涉嫌信息披露违法违规，证监会决定对本公司 立案。截至本公告披露日，公司未收到最终调查结果。如公司存在《上市公司监 管指引第 11 号——上市公司破产重整相关事项》第四条"涉及欺诈发行、重大 信息披露违法或者其他严重损害证券市场秩序的重大违法行为""控股股东、实 际控制人及其他关联方违规占用上市公司资金、利用上市公司为其提供担保"等 情形的，重整事项能否继续推进将存在重大不确定性。 2、因 2024 年度财报被出具无法表示意见审计报告及否定意见内部控制，公 司股票已被实施退市风险警示和其他风险警示；若 2025 年度未解决退市风险事 项，公司股票将面临终止 ...

Group 1 - The silicon energy sector is experiencing a significant rally, with *ST Xinyuan (300472) hitting a 20% limit up, and Daqo Energy rising over 7% [1] - Other companies such as Oujing Technology (001269), Tongwei Co., Ltd. (600438), and Dongyue Silicon Material (300821) are also seeing gains [1] - Previously, the main contract for polysilicon on the Shanghai Futures Exchange has seen its increase expand to 5% [1] Group 2 - There is a notable influx of dark pool funds into these stocks, indicating strong investor interest [1]

Core Viewpoint - *ST XinYuan (300472) has experienced a significant stock price surge after being applied for reorganization by creditors, indicating potential for recovery despite facing delisting risks and ongoing legal issues [1][3][5]. Group 1: Company Financials and Performance - *ST XinYuan has been in a precarious financial situation, with a reported revenue of only 1.31 billion and a net loss of 442 million for the year 2024, alongside overdue debts totaling 183 million [6]. - The company has faced continuous losses for five years, with a cumulative stock price drop of 53% in 2023, leading to a market capitalization of only 842 million, the lowest among A-shares excluding those in delisting procedures [4][6]. - In the first quarter of 2025, the company reported a revenue of 380.83 million and a net loss of 17.23 million [6]. Group 2: Legal and Regulatory Issues - The company is under investigation by the China Securities Regulatory Commission for alleged information disclosure violations, which has led to significant adjustments in its financial statements, including a reduction of 1.67 billion in 2022 revenue [7]. - The company has been involved in multiple lawsuits, with a total of 572.88 million in unresolved legal cases reported within the last 12 months [8]. - The company's actual controller and chairman have been restricted from high consumption due to ongoing legal issues [8]. Group 3: Market Reaction and Future Outlook - Following the announcement of the reorganization application, *ST XinYuan's stock price hit the daily limit up of 20%, increasing its market value to 1.01 billion [5]. - The potential for reorganization could improve the company's financial structure and promote healthier development, although the success of this process remains uncertain [4].

公司于 2025 年 3 月 27 日收到中国证券监督管理委员会（以下简称"证监会") 下发的《立案告知书》，因涉嫌信息披露违法违规，证监会决定对本公司立案。 截至本公告披露日，公司未收到最终调查结果。如公司存在《上市公司监管指引 第 11 号——上市公司破产重整相关事项》第四条"涉及欺诈发行、重大信息披 露违法或者其他严重损害证券市场秩序的重大违法行为""控股股东、实际控制 人及其他关联方违规占用上市公司资金、利用上市公司为其提供担保"等情形的， 重整事项能否继续推进将存在重大不确定性。 证券代码：300472 证券简称：*ST 新元 公告编号：临-2025-078 万向新元科技股份有限公司 关于重整及相关事项的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或者重大遗漏。 万向新元科技股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日披露 了《关于公司被债权人申请重整及预重整的提示性公告》（公告编号：临 -2025-075），现将相关风险再次提示如下： 1、公司因涉嫌信息披露违法违规被证监会立案调查，最终调查结果未出， 重整推进存在重大不确 ...

证券代码：300472 证券简称：*ST 新元 公告编号：临-2025-077 万向新元科技股份有限公司 关于授权成立"过渡期临时工作组"的公告 公司全体董事会成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为保障过渡期内董事会相关职能的有序行使，有效化解公司所面临的经营困 境、债务危机及退市风险，提请公司董事会特此授权工作组行使以下职能： 风险提示： 1、"过渡期临时工作组"仅在授权范围内行使职能，公司重大事项仍应依 照《公司法》《公司章程》及相关法规，履行董事会、股东会的正式审批程 序。 2、公司全资子公司天津万向和宁夏万向目前处于临时停产状态，根据《深 圳证券交易所创业板股票上市规则（2025 年修订）》第 9.4 条第（一）项规 定，如果公司生产经营活动受到严重影响且预计在三个月以内不能恢复正常 的，深圳证券交易所将对公司股票叠加实施其他风险警示。 万向新元科技股份有限公司（以下简称"公司"）于 2025 年 6 月 30 日召 开公司第五届董事会第十次会议，审议通过了《关于授权成立"过渡期临时工 作组"的紧急议案》。具体情况如下: 为有效化解公司目前面临的债务危机及退 ...

证券代码：300472 证券简称：*ST 新元 公告编号：临-2025-076 万向新元科技股份有限公司 第五届董事会第十次会议决议公告 为有效化解公司目前面临的债务危机及退市风险，特此提议董事会成立"过 渡期临时工作组"（以下简称"工作组"）。在过渡期内，工作组将在董事长的 领导下通过友好协商与集体决策机制履行由董事会授予的相关职能，并负责向董 事会汇报。 "过渡期临时工作组"仅在授权范围内行使职能，公司重大事项仍应依照《公 司法》《公司章程》及相关法规，履行董事会、股东会的正式审批程序。 具体内容见公司同日于巨潮资讯网披露的《关于董事会授权成立"过渡期临 时工作组"的公告》（公告编号：临-2025-077）。 万向新元科技股份有限公司（以下简称"公司"）第五届董事会第十次会议 （以下简称"本次会议"）于 2025 年 6 月 30 日以通讯表决方式召开。因审议事 项紧急，经全体与会董事同意豁免会议通知时间要求。本次会议由董事长吴贤龙 先生主持，应出席本次会议的董事 6 人，实际出席本次会议的董事 6 人。会议召 开符合 《中华人民共和国公司法》《公司章程》的规定，会议合法有效。 经与会董事审议表决，通过了 ...

证券代码：300472 证券简称：*ST 新元 公告编号：临-2025-074 万向新元科技股份有限公司 关于公司银行贷款逾期暨重大诉讼的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1、案件所处的诉讼阶段：已立案，尚未开庭审理 2、公司所处的当事人地位：被告 3、涉案的金额：20,006,464.5 元及利息 4、对公司损益产生的影响：目前案件尚未开庭审理，该诉讼事项对公司本 期利润或期后利润的具体影响尚存在不确定性。 一、银行贷款逾期进展及诉讼情况 万向新元科技股份有限公司（以下简称"公司"）于 2025 年 2 月 19 日在中 国证监会指定的创业板信息披露网站上刊登《关于公司和子公司银行贷款逾期的 公告》（临-2025-018），公司与兴业银行股份有限公司北京房山支行（以下简 称"兴业银行房山支行"）签订国内反向保理业务协议书，借款金额 1920 万元 已逾期。近日，公司收到北京市房山区人民法院送达的《民事传票》（案号：（2025） 京 0111 民初 12853 号）及相关诉讼材料，兴业银行房山支行就上述逾期贷款向 公司提起诉 ...

万向新元科技股份有限公司董事会 2025年6月27日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 万向新元科技股份有限公司(以下简称"公司")于 2025 年 4 月 30 日在巨潮 资讯网上披露《关于延期披露会计差错更正专项鉴证报告的提示性公告》（公告 编号：临-2025-041），根据《公开发行证券的公司信息披露编报规则第 19 号— —财务信息的更正及相关披露》等有关规定，公司应聘请符合《证券法》规定的 会计师事务所针对前期会计差错更正事项出具专项鉴证报告。公司预计将自公告 披露之日起两个月内完成本次会计差错更正专项鉴证报告的披露工作。 截至本公告披露日，公司及各相关方正在积极配合并全力推进前期会计差错 更正事项的核查工作。由于此次前期会计差错更正专项鉴证所涉及的工作复杂、 工作量较大，需执行更多的核查程序，公司预计将延期至 2025 年 8 月 31 日前完 成会计差错更正专项鉴证报告的披露工作。敬请广大投资者注意投资风险。 特此公告。 证券代码：300472 证券简称：*ST新元 公告编号：临-2025-073 万向新元科技股份有限公司 关于再次 ...

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]